You have 9 free searches left this month | for more free features.

City

Berlin (1)

Edegem (1)

San Antonio (1)

South Miami (1)

Condition

Contraception (2)

Change in Bone Mineral Density (1)

Healthy Female (1)

Overweight (1)

Overall Status

Not yet recruiting (3)

Completed (1)

Sign in for free

Phase

phase 1 (2)

phase 3 (1)

Sponsor

Center for Epidemiology and Health Research, Germany (1)

Eli Lilly and Company (1)

Insud Pharma (1)

Janssen Pharmaceutica N.V., Belgium (1)

Collaborator

Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma (1)

Bristol Myers Squibb Company (BMS) (1)

Chemo Research (1)

Intervention

drospirenone (4)

ethinyl estradiol (1)

ethinylestradiol (1)

levonorgestrel (1)

ly3437943 (1)

midazolam (1)

milvexian (1)

other progestin containing oral contraceptive (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (3)

Observational (1)

drospirenone

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Overweight Trial in South Miami, San Antonio (LY3437943, Ethinyl Estradiol, Drospirenone)

Not yet recruiting

Overweight

LY3437943
+2 more

South Miami, Florida
+1 more

Sep 11, 2023

Healthy Female Trial in Edegem (Milvexian, Midazolam, Ethinylestradiol)

Not yet recruiting

Healthy Female

Milvexian
+3 more

Edegem, Belgium

SGS Belgium NV

Jan 23, 2023

Contraception, Change in Bone Mineral Density Trial (Drospirenone)

Not yet recruiting

Contraception
Change in Bone Mineral Density

Drospirenone

(no location specified)

Jul 13, 2022

European Active Surveillance Study (EURAS)

Completed

Has Results

Contraception

Drospirenone
+2 more

Berlin, Germany

Center for Epidemiology and Health Research

Nov 6, 2009